If you're interested in exploring whether microdosing may be right for you, you can: Our providers currently serve patients in North Carolina, South Carolina, Texas, New York, Arizona, Florida, Maryland, and additional states
A study utilizing a national database found that individuals treated with GLP-1 receptor agonists had a significantly lower risk of developing glaucoma compared to those who were not on these medications
Start an online weight-loss consultation with Omnia Telehealth and let a licensed provider help you choose and start safely
In people with type two diabetes and are at cardiovascular risk, several GLP ones cut major events too
Prebiotic Fiber Blend: Daily Fiber is formulated with 10g of soluble fiber that supports satiety and feeds probiotics and a clinically studied, shelf-stable prebiotic that supports microflora balance and regularity
Chest pain is not listed as a common adverse effect in the FDA-approved prescribing information for tirzepatide